Needham downgraded dental product makers Dentsply Sirona (NASDAQ:XRAY) and ZimVie (NASDAQ:ZIMV) to Hold from Buy on Thursday, ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor ...

Mizuho lowered the firm’s price target on Dentsply Sirona (XRAY) to $18 from $21 and keeps a Neutral rating on the shares following the ...

Needham downgraded Dentsply Sirona and ZimVie, citing weak growth, market share losses, and demand challenges amid high ...

NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Week Low Dividend Stocks To Avoid. In this article, we are going to take a look at where DENTSPLY SIRONA Inc. (NASDAQ:XRAY) ...

Dentsply Sirona faces growth challenges with weak Q4 results and limited exposure to high-growth dental segments.

Dental products company Dentsply Sirona (NASDAQ:XRAY) will be announcing earnings results tomorrow morning. Here’s what you need to know.

Stock analysts at Leerink Partnrs dropped their Q1 2025 earnings per share estimates for shares of DENTSPLY SIRONA in a ...

State of Michigan Retirement System lessened its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by ...

Learn more about whether Enovis Corporation or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades ...

Needham downgraded Dentsply Sirona and ZimVie to Hold from Buy, citing a lack of near-term catalysts and continued weakness in the dental market.